1. Home
  2. ACTG vs RZLT Comparison

ACTG vs RZLT Comparison

Compare ACTG & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acacia Research Corporation (Acacia Tech)

ACTG

Acacia Research Corporation (Acacia Tech)

HOLD

Current Price

$5.02

Market Cap

384.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.26

Market Cap

326.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACTG
RZLT
Founded
1993
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
384.9M
326.4M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
ACTG
RZLT
Price
$5.02
$3.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$6.00
$9.67
AVG Volume (30 Days)
455.8K
3.1M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
161.11
26.32
EPS
0.22
N/A
Revenue
$12,004,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.70
$1.07
52 Week High
$5.21
$11.46

Technical Indicators

Market Signals
Indicator
ACTG
RZLT
Relative Strength Index (RSI) 64.88 56.67
Support Level $4.77 $2.87
Resistance Level $5.21 $3.66
Average True Range (ATR) 0.16 0.28
MACD -0.02 0.07
Stochastic Oscillator 56.18 71.53

Price Performance

Historical Comparison
ACTG
RZLT

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: